Chinese drug regulators completed an expert panel review of a COVID-19 mRNA vaccine co-developed by Fosun Pharma and Germany's BioNTech, and now the shot is in the administrative review stage, according to Fosun.
Caixin
China to use BioNTech vaccine as booster shot, sources say
Joint venture with Fosun Pharma to make 100m to 200m vaccines a month
